NEW YORK, Feb 10 (Reuters) - Johnson & Johnson said its Cordis medical devices unit, whose sales have fallen sharply in recent years due to waning demand for its Cypher heart stent, will lay off an unspecified number of salespeople and merge two separate sales forces within the division.
